loadpatents
name:-0.018869876861572
name:-0.0081071853637695
name:-0.00040602684020996
Miwa; Masanori Patent Filings

Miwa; Masanori

Patent Applications and Registrations

Patent applications and USPTO patent grants for Miwa; Masanori.The latest application filed is for "5-substituted-2-phenylamino benzamides as mek inhibitors".

Company Profile
0.8.14
  • Miwa; Masanori - Kanagawa N/A JP
  • Miwa; Masanori - Osaka JP
  • Miwa; Masanori - Kamakura-shi JP
  • Miwa; Masanori - Ibaraki JP
  • Miwa; Masanori - Kitakyushu JP
  • Miwa, Masanori - Tshukuba-shi JP
  • Miwa, Masanori - Kitayushu-shi JP
  • Miwa, Masanori - Tsukuba-shi JP
  • Miwa; Masanori - Kamakura JP
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
5-substituted-2-phenylamino benzamides as MEK inhibitors
Grant 8,575,391 - Isshiki , et al. November 5, 2
2013-11-05
4-phenylamino-benzaldoxime derivatives and uses thereof as mitogen-activated protein kinase kinase (MEK) inhibitors
Grant 8,084,645 - Isshiki , et al. December 27, 2
2011-12-27
5-Substituted-2-Phenylamino Benzamides as Mek Inhibitors
App 20100197676 - Isshiki; Yoshiaki ;   et al.
2010-08-05
5-Substituted-2-phenylamino benzamides as MEK inhibitors
Grant 7,745,663 - Isshiki , et al. June 29, 2
2010-06-29
5-Substituted-2-Phenylamino Benzamides as MEK Inhibitors
App 20090233915 - Isshiki; Yoshiaki ;   et al.
2009-09-17
Screening method
Grant 7,354,726 - Hinuma , et al. April 8, 2
2008-04-08
4-Phenylamino-benzaldoxime derivatives and uses thereof as mitogen-activated protein kinase kinase (mek) inhibitors
App 20070105859 - Isshiki; Yoshiaki ;   et al.
2007-05-10
Method for the treatment of cancer using a novel pharmaceutical composition containing at least one dolastatin 10 derivative
App 20060292158 - Aoki; Yuko ;   et al.
2006-12-28
Novel g protein-coupled receptor protein and dna thereof
App 20060057663 - Miwa; Masanori ;   et al.
2006-03-16
Rail producing method and producing equipment
Grant 6,931,703 - Onodera , et al. August 23, 2
2005-08-23
Screening method
App 20040171067 - Hinuma, Syuji ;   et al.
2004-09-02
Novel g protein-coupled receptor protein and dna thereof
App 20040072751 - Miwa, Masanori ;   et al.
2004-04-15
Novel g protein-coupled receptor protein and dna thereof
App 20040067553 - Miwa, Masanori ;   et al.
2004-04-08
Novel g protein-coupled receptor protein and dna thereof
App 20040048263 - Miwa, Masanori ;   et al.
2004-03-11
Novel g protein-coupled receptor proteins and dnas thereof
App 20030191285 - Miwa, Masanori ;   et al.
2003-10-09
Rail producing method and producing equipment
App 20030168135 - Onodera, Noriaki ;   et al.
2003-09-11
Novel g protein-coupled receptor protein and dna thereof
App 20030166000 - Miwa, Masanori ;   et al.
2003-09-04
Novel g protein-coupled receptor protein and dna thereof
App 20030162252 - Miwa, Masanori ;   et al.
2003-08-28
Novel g-protein-coupled receptor protein and dna thereof
App 20030087287 - Miwa, Masanori ;   et al.
2003-05-08
N.sup.4 -(substituted-oxycarbonyl)-5'-deoxy-5-fluorocytidine compounds, compositions and methods of using same
Grant 5,472,949 - Arasaki , et al. December 5, 1
1995-12-05
Fluorocytidine derivatives
Grant 4,966,891 - Fujiu , et al. October 30, 1
1990-10-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed